IMU Ann: IMUGENE DOSES FIRST PATIENT IN VAXINIA PHASE 1 TRIAL - 18th May 2022, 8:22am

annb0t

annb0t

Top 20
IMU Ann: IMUGENE DOSES FIRST PATIENT IN VAXINIA PHASE 1 TRIAL
Price Sensitive: Y
Date: 18th May 2022, 8:22am

>>> Read announcement: Google: IMU Market Announcements
 
  • Fire
Reactions: 1 users
You must log in or register to reply here.

Similar threads

annb0t
IMU Ann: Imugene Phase 1 onCARlytics CD19 virus clinical trial opens - 26th Oct 2023, 9:08am
Replies
0
Views
109
annb0t
annb0t
annb0t
IMU Ann: Imugene B Cell & OV Platforms Featured at ESMO Congress - 24th Oct 2023, 9:44am
Replies
0
Views
143
annb0t
annb0t
annb0t
IMU Ann: Imugene ESG Report 2023 - 29th Sep 2023, 4:36pm
Replies
0
Views
95
annb0t
annb0t
annb0t
IMU Ann: Azer-cel FDA IND Transferred to Imugene - 28th Sep 2023, 9:15am
Replies
0
Views
106
annb0t
annb0t
annb0t
IMU Ann: Imugene Closes SPP Raising $18.2 million - 25th Sep 2023, 9:32am
Replies
0
Views
114
annb0t
annb0t
Top Bottom